Company news
Knight Therapeutics, Inc. news in 2019
Knight Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Medison Expresses Concerns over Knight Therapeutics' Second Quarter Results and Demands Answers to Critical Questions from Jonathan Goodman
August 9, 2019
Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Qualified Nominees at Upcoming Annual Meeting
April 29, 2019
Leading Independent Proxy Advisory Firm ISS Recommends Change at Knight Therapeutics
April 25, 2019
Medison Issues Presentation to Knight Shareholders
April 18, 2019
Leading Canadian Corporate Governance Expert Confirms Acute Board Conflicts and Governance Deficiencies at Knight Therapeutics
April 17, 2019
Medison Issues Letter to Shareholders of Knight Therapeutics, Outlining Qualified, Independent Director Nominees and Common-Sense Plan to Build Value
April 16, 2019
Medison Disappointed that Knight Therapeutics has Resorted to Blatant Misrepresentations to Avoid Scrutiny
April 10, 2019
Medison Files Proxy Circular, Offers Knight Therapeutics Shareholders Truly Independent, Unconflicted Directors and Comprehensive Business Plan to Fix a Failing Knight
April 8, 2019
Medison to Nominate Six Highly Qualified Directors for Knight Therapeutics' Board to Strengthen Oversight and Drive Value Creation for All Shareholders
April 1, 2019
Decks in 2019
- Investor Presentation (August 2019)
Investor deck · 29 slides · August 2019